difference between glp-1 and gip Understanding vs. Medications: What's the Difference? - Ketamine Solutions Dose-equivalence reference based on pivotal

No hassle, no risk

Recently, the newly developed drug tirzepatide, which targets both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, was introduced to the market to treat type 2 diabetes and obesity in 2022 and 2023, respectively (Table 1)

18 Although treatments are available for diabetes and obesity, there are multiple long-term complications: they remain the leading causes of cardiovascular disease, eye pathology, lower limb amputation and end-stage renal disease

It can be beneficial for a wide range of conditions, including chronic infections, autoimmune diseases, arthritis, cardiovascular conditions, and more

If the value is lower, intake can be adjusted accordingly